Scripps Translational Science Institute
La Jolla, California, 92037, United States
NCT Number: NCT01517425
This research is being done to understand how changes in DNA may put people at risk for developing coronary artery disease. Stem cells will be made using cells from blood and/or skin biopsy samples. We are trying to understand which specific changes in DNA negatively impact a person's health.
Interested in participating?
Request Info18 year and older
All sexes
Observational
La Jolla, California, 92037, United States
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Cases:
Controls:
Exclusion criteria
Time frame: five years
Develop methods of iPSC generation from patients with genomic risk.
Scripps Translational Science Institute
Other
Acronym: iPSC
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT06374498
Arterial Occlusive Diseases, Arteriosclerosis
Boston, Massachusetts, United States
View Trial DetailsNCT07480629
Antiplatelet Therapy of Coronary Artery Bypass, Arterial Occlusive Diseases
Shanghai, China
View Trial DetailsNCT07625488
Arterial Occlusive Diseases, Arteriosclerosis
Nijmegen, Netherlands
View Trial DetailsNCT07416344
Arterial Occlusive Diseases, Arteriosclerosis
Daqing, Heilongjiang, China
View Trial Details